More than 30% of patients with classic clinical manifestations of MEN-1 do not have an identified MEN1 gene mutation in the coding region and splice sites, in these cases, further testing such as partial or complete deletion testing, MEN1 locus haplotype analysis, or additional gene analysis should be considered (7, 14). The gene discussed is MEN1; the disease is multiple endocrine neoplasia type 1.